Welcome to this week’s edition of Weekend Wonderings. I hope that everyone has enjoyed their 4th of July celebrations and are finding relaxing family time this weekend. Grab whatever beverage that you need and let’s proceed.
Obviously, a cancer patient goes through numerous and profound physical and emotional changes during treatment. Here is a list of several physical changes to expect.
Here is a great pic of the new James Hospital framed by a rainbow.
Finally, here is a brief video introducing the BMT (Bone Marrow Transplant) Unit at the new James.
Welcome to this week’s edition of Weekend Wonderings. Here we are, end of June, which means we are getting closer to football season. If your appetite needs whetting, you can check out Patrick’s weekly season opponent preview series. Since your appetite is now properly whetted, grab whatever beverage that you need, appropriate for time of day of course, and let’s proceed.
We have a little something regarding The James, some baseball and our Sunday Song. Of course, accompanied by our article soundtrack from Maroon 5.
Welcome to this week’s edition of Weekend Wonderings. We have tidbits regarding The James, a couple miscellaneous commentary topics and a musical finale. Fire up the speakers, cause it’s Sunday morning!
Grab your beverage and let’s proceed.
Here is some research from the folks at The James regarding the use of a deadly life form, a virus, along with a cancer targeting agent to kill cancer cells. This is a creation of a hunter-killer approach to cancer treatment and therapy.
Giving low doses of a particular targeted agent with a cancer-killing virus might improve the effectiveness of the virus as a treatment for cancer, according to a study led by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).
Viruses designed to kill cancer cells are being used in clinical trials to treat brain cancer and other malignancies.
This study suggests that combining a particular targeted agent with a cancer-killing virus might improve the virus’s ability to kill cancer cells.
The findings support the testing of this combination therapy in a clinical trial.
In other news, Dr. Carbone of The James discusses specific biomarkers to assist in diagnosis and treatment of lung cancer. It’s a long, long journey, but, small steps, folks..
Talkin’ Football: Musician Jon Bon Jovi’s name has been bandied about as a potential buyer for the Buffalo Bills.
That’s fine with me — someone has to own them. Read More
Welcome to this week’s edition of Weekend Wonderings. Grab whatever beverage that you need (coffee is nice, see above) and let’s proceed. We’ll have some news from The James, some miscellaneous commentary and wrap it up with a track by Eric Clapton.
Here is an interesting example of cross-fertilization between departments and between universities.
The Ohio State University and the University of Michigan have signed an exclusive worldwide agreement with Ohio-based Venture Therapeutics Inc., to form a new company to develop and commercialize a pharmaceutical technology targeted for the treatment of precancerous oral lesions.
Previously published data shows that about 30% of the higher grade precancerous oral lesions progress to oral cancer, specifically oral squamous cell carcinoma. This type of cancer is particularly devastating to patients because treatment entails removal of facial and mouth structures essential for esthetics and function. The National Cancer Institute estimates that 42,440 Americans will be diagnosed with oral cancer and over 8,390 oral cancer related deaths will occur in 2014.
This is a pretty big deal where OSU interdisciplines (dentistry and oncology) team up with UM staff for this new treatment protocol. Buckeyes and Wolverines may not care for one another on the field/court, but when it counts, it counts..
Welcome to this week’s edition of Weekend Wonderings. I hope that you notice the new header (above) that is the end result of efforts from tBBC’s Arts & Graphics Department. (Thanks, Joe). This is a “says it all” graphic; the James is in the background and our beverage if coffee. Another addition, the weekly embed of Sunday Morning. I hope that you enjoy the new look.
This week we’ll touch on a couple articles concerning The James, have some golf tips and of course, close things out with our Sunday Song. Grab your beverage and let’s proceed.
Welcome to another edition of Weekend Wonderings. Grab whatever beverage that you need and let’s proceed. Go ahead, take whatever time you need, I’ll wait.
We’ve got the usual updates from The James, a couple items that would not please Giordano Bruno (right) and a song that will get you in the mood to finish your Spring Cleaning. You’re welcome.
This August marks the 6th anniversary of Pelotonia, the annual fundraising bicycle tour held on behalf of the James. If you can get out to ride and raise funds, great. If you can’t, I’m sure that any number of riding teams will be glad to accept any donation from you for their efforts. My wife & I don’t ride, but this is our 2nd year supporting a similar endeavour, “Ride For Roswell“, in memory of our neighbor, Mark. Go ahead and get involved; lots of people, including yourself, will be glad that you did.
Welcome to this week’s edition of Weekend Wonderings. Grab whatever beverage that you need and let’s proceed. In fact, this is a 3-day weekend, so you’d better grab an extra one while you’re up.
And, yes, let’s give thanks to these gentlemen on the right, and their fellow servicemen, who made the sacrifices that we can do what we do today.
Last week, I touched upon a new genetically modified treatment of T-cells to attack and kill multiple myeloma tumors. The research team’s recommendation was to proceed with clinical trials. Well, here’s a tour of the new Clinical Trial area under construction at The James.
Moving on, guys, one in seven of us will be diagnosed with prostate cancer. It’s not always “the other guy”, because at some point we start to run out of ‘other guys’. Here is some information for you from Channel 10 TV and The James.
Commentary Read More
Welcome to this week’s edition of Weekend Wonderings. Grab whatever beverage that you need and let’s proceed. My Lovely Bride and I will. You can be sure of that. This coming week we’ll be taking a couple days off to celebrate our 25th wedding anniversary. As I tell her, it’s been the best 25 (26 if you count courtship) years of my life. To no one’s surprise, we both agree on that sentiment.
This is of some interest: researchers at the James have genetically modified immune cells (T-cells) that hunt down and kill cancer cells, multiple myeloma, in this case, themselves a product of genetic “modification”. Below are the quick hitters.
A new study by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) provides evidence that genetically modifying immune cells might effectively treat multiple myeloma, a disease that remains incurable and will account for an estimated 24,000 new cases and 11,100 deaths in 2014.
The researchers modified a type of human immune cell – called T lymphocytes, or T cells – to target a molecule called CS1, which is found on more than 95 percent of myeloma cells, and to kill the cells. The researchers grew the modified cells in the lab to increase their numbers and then injected them into an animal model where they again killed human myeloma cells.